Roberta Sclocco1, Ronald G Garcia2, Norman W Kettner3, Harrison P Fisher4, Kylie Isenburg4, Maya Makarovsky4, Jessica A Stowell5, Jill Goldstein6, Riccardo Barbieri7, Vitaly Napadow8. 1. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; Department of Radiology, Logan University, Chesterfield, MO, USA. Electronic address: roberta@nmr.mgh.harvard.edu. 2. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; School of Medicine, Universidad de Santander (UDES), Bucaramanga, Colombia. 3. Department of Radiology, Logan University, Chesterfield, MO, USA. 4. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA. 5. Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 6. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; Department of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 7. Department of Electronics, Information and Bioengineering, Politecnico di Milano, Italy; Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 8. Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USA; Department of Radiology, Logan University, Chesterfield, MO, USA.
Abstract
BACKGROUND: The therapeutic potential of transcutaneous auricular VNS (taVNS) is currently being explored for numerous clinical applications. However, optimized response for different clinical indications may depend on specific neuromodulation parameters, and systematic assessments of their influence are still needed to optimize this promising approach. HYPOTHESIS: We proposed that stimulation frequency would have a significant effect on nucleus tractus solitarii (NTS) functional MRI (fMRI) response to respiratory-gated taVNS (RAVANS). METHODS: Brainstem fMRI response to auricular RAVANS (cymba conchae) was assessed for four different stimulation frequencies (2, 10, 25, 100 Hz). Sham (no current) stimulation was used to control for respiration effects on fMRI signal. RESULTS: Our findings demonstrated that RAVANS delivered at 100 Hz evoked the strongest brainstem response, localized to a cluster in the left (ipsilateral) medulla and consistent with purported NTS. A co-localized, although weaker, response was found for 2 Hz RAVANS. Furthermore, RAVANS delivered at 100 Hz also evoked stronger fMRI responses for important monoamine neurotransmitter source nuclei (LC, noradrenergic; MR, DR, serotonergic) and pain/homeostatic regulation nuclei (i.e. PAG). CONCLUSION: Our fMRI results support previous localization of taVNS afference to pontomedullary aspect of NTS in the human brainstem, and demonstrate the significant influence of the stimulation frequency on brainstem fMRI response.
BACKGROUND: The therapeutic potential of transcutaneous auricular VNS (taVNS) is currently being explored for numerous clinical applications. However, optimized response for different clinical indications may depend on specific neuromodulation parameters, and systematic assessments of their influence are still needed to optimize this promising approach. HYPOTHESIS: We proposed that stimulation frequency would have a significant effect on nucleus tractus solitarii (NTS) functional MRI (fMRI) response to respiratory-gated taVNS (RAVANS). METHODS: Brainstem fMRI response to auricular RAVANS (cymba conchae) was assessed for four different stimulation frequencies (2, 10, 25, 100 Hz). Sham (no current) stimulation was used to control for respiration effects on fMRI signal. RESULTS: Our findings demonstrated that RAVANS delivered at 100 Hz evoked the strongest brainstem response, localized to a cluster in the left (ipsilateral) medulla and consistent with purported NTS. A co-localized, although weaker, response was found for 2 Hz RAVANS. Furthermore, RAVANS delivered at 100 Hz also evoked stronger fMRI responses for important monoamine neurotransmitter source nuclei (LC, noradrenergic; MR, DR, serotonergic) and pain/homeostatic regulation nuclei (i.e. PAG). CONCLUSION: Our fMRI results support previous localization of taVNS afference to pontomedullary aspect of NTS in the human brainstem, and demonstrate the significant influence of the stimulation frequency on brainstem fMRI response.
Authors: Diego Antonino; André L Teixeira; Paulo M Maia-Lopes; Mayara C Souza; Jeann L Sabino-Carvalho; Aaron R Murray; Jim Deuchars; Lauro C Vianna Journal: Brain Stimul Date: 2017-05-19 Impact factor: 8.955
Authors: Vladimir Fonov; Alan C Evans; Kelly Botteron; C Robert Almli; Robert C McKinstry; D Louis Collins Journal: Neuroimage Date: 2010-07-23 Impact factor: 6.556
Authors: Jennifer A Clancy; David A Mary; Klaus K Witte; John P Greenwood; Susan A Deuchars; Jim Deuchars Journal: Brain Stimul Date: 2014-07-16 Impact factor: 8.955
Authors: Samantha M Meints; Ronald G Garcia; Zev Schuman-Olivier; Michael Datko; Gaelle Desbordes; Marise Cornelius; Robert R Edwards; Vitaly Napadow Journal: Pain Med Date: 2022-08-31 Impact factor: 3.637
Authors: Adam D Farmer; Adam Strzelczyk; Alessandra Finisguerra; Alexander V Gourine; Alireza Gharabaghi; Alkomiet Hasan; Andreas M Burger; Andrés M Jaramillo; Ann Mertens; Arshad Majid; Bart Verkuil; Bashar W Badran; Carlos Ventura-Bort; Charly Gaul; Christian Beste; Christopher M Warren; Daniel S Quintana; Dorothea Hämmerer; Elena Freri; Eleni Frangos; Eleonora Tobaldini; Eugenijus Kaniusas; Felix Rosenow; Fioravante Capone; Fivos Panetsos; Gareth L Ackland; Gaurav Kaithwas; Georgia H O'Leary; Hannah Genheimer; Heidi I L Jacobs; Ilse Van Diest; Jean Schoenen; Jessica Redgrave; Jiliang Fang; Jim Deuchars; Jozsef C Széles; Julian F Thayer; Kaushik More; Kristl Vonck; Laura Steenbergen; Lauro C Vianna; Lisa M McTeague; Mareike Ludwig; Maria G Veldhuizen; Marijke De Couck; Marina Casazza; Marius Keute; Marom Bikson; Marta Andreatta; Martina D'Agostini; Mathias Weymar; Matthew Betts; Matthias Prigge; Michael Kaess; Michael Roden; Michelle Thai; Nathaniel M Schuster; Nicola Montano; Niels Hansen; Nils B Kroemer; Peijing Rong; Rico Fischer; Robert H Howland; Roberta Sclocco; Roberta Sellaro; Ronald G Garcia; Sebastian Bauer; Sofiya Gancheva; Stavros Stavrakis; Stefan Kampusch; Susan A Deuchars; Sven Wehner; Sylvain Laborde; Taras Usichenko; Thomas Polak; Tino Zaehle; Uirassu Borges; Vanessa Teckentrup; Vera K Jandackova; Vitaly Napadow; Julian Koenig Journal: Front Hum Neurosci Date: 2021-03-23 Impact factor: 3.169
Authors: Giuseppe Forte; Erik Leemhuis; Francesca Favieri; Maria Casagrande; Anna Maria Giannini; Luigi De Gennaro; Mariella Pazzaglia Journal: J Pers Med Date: 2022-03-01